Keyword Index

A

adenovirus vector　→　5. Pharmacology Division
AKT2 oncogene　→　13. Oncogene Division
AML1-MTG8　→　8. Radiobiology Division
angiogenesis　→　15. Section for Studies on Metastasis
angiogenesis inhibitor　→　7. Growth Factor Division
antimetastatic activity　→　3. Chemotherapy Division
apoptosis　→　6. Biophysics Division

B

bladder cancer　→　3. Chemotherapy Division
bone morphogenetic protein (BMP)　→　15. Section for Studies on Metastasis
breast cancer　→　17. Pathology Division

C

c-erbB-2　→　1. Pathology Division
cachexia　→　7. Growth Factor Division
cadherin　→　1. Pathology Division
calcium-binding protein　→　7. Growth Factor Division
carcinogenesis　→　14. Carcinogenesis Division
catenin　→　1.Pathology Division
cell cycle progression　→　7. Growth Factor Division
chemopreventive agent　→　3. Chemotherapy Division
chromosomal instability　→　12. Genetics Division
chronic gastritis　→　16. Section for Studies on Host-immune Response
clinicopathological assessment　→　17. Pathology Division
clonality　→　19. Investigative Treatment Division
cohort　→　18. Epidemiology and Biostatistics Division
colon carcinogenesis　→　11. Cancer Prevention Division
computer-assisted image diagnosis system　→　17. Pathology Division
comutagenic action　→　2. Biochemistry Division
coping　→　20. Psychooncology Division

D

delirium　→　20. Psychooncology Division
depression　→　20. Psychooncology Division
dietary factor　→　18. Epidemiology and Biostatistics Division
DNA methylation　→　1. Pathology Division
DNA-testing　→　7. Growth Factor Division
docosahexaenoic acid (DHA)　→　11. Cancer Prevention Division
Down syndrome (DS) region　→　8. Radiobiology Division

E

ectopic hormone/cytokine syndrome　→　7. Growth Factor Division
epidemiology　→　9. Cancer Information and Epidemiology Division
etiology　→　18. Epidemiology and Biostatistics Division

F

familial cancer　→　9. Cancer Information and Epidemiology Division
FISH　→　1. Pathology Division
flat-type adenocarcinoma　→　19. Investigative Treatment Division
FUS-ERG　→　8. Radiobiology Division

G

ganglioside GM2　→　5. Pharmacology Division
gene amplification　→　12. Genetics Division
genomic instability　→　4. Biology Division
gnidimacrin　→　5. Pharmacology Division
granulocyte colony-stimulating factor receptor (G-CSFR)　→　8. Radiobiology Division

H

HCV protein　→　10. Virology Division
HCV replication system　→　10. Virology Division
Helicobacter pylori　→　16. Section for Studies on Host-immune Response
hepatitis C virus (HCV)　→　10. Virology Division
heterocyclic amine (HCA)　→　14. Carcinogenesis Division
HST-1　→　12. Genetics Division
HTLV-I-infected T-cell　→　10. Virology Division
human chromosome 11　→　8. Radiobiology Division
human chromosome 16　→　1. Pathology Division
human T-cell leukemia virus　→　10. Virology Division
hypercalcemia　→　7. Growth Factor Division

I

information　→　9. Cancer Information and Epidemiology Division
intermediate TCR (TCRint)　→　16. Section for Studies on Host-immune Response
internet　→　17. Pathology Division
intervention study　→　18. Epidemiology and Biostatistics Division
invasion　→　1. Pathology Division

K

K-ras　→　15. Section for Studies on Metastasis, 19. Investigative Treatment Division

L

LEC　→　14. Carcinogenesis Division
lung cancer　→　4. Biology Division

M

MeIQx-DNA adduct　→　2. Biochemistry Division
metastasis　→　1. Pathology Division, 4. Biology Division
molecular therapeutics　→　7. Growth Factor Division
monoclonal antibody　→　16. Section for Studies on Host-immune Response
multiple endocrine neoplasia (MEN) type 2　→　7. Growth Factor Division

N

nimesulide　→　11. Cancer Prevention Division
nitric oxide (NO)　→　11. Cancer Prevention Division, 19. Investigative Treatment Division
norharman　→　2. Biochemistry Division

O

okadaic acid (OA)　→　14. Carcinogenesis Division
oncogene　→　4. Biology Division

P

paclitaxel　→　5. Pharmacology Division
pancreatic cancer (neoplasm)　→　15. Section for Studies on Metastasis, 17. Pathology Division
pierisin　→　2. Biochemistry Division
poly(ADP-ribose) polymerase (PARP)　→　2. Biochemistry Division
prevention　→　11. Cancer Prevention Division, 18. Epidemiology and Biostatistics Division
ProGRP　→　7. Growth Factor Division
prostate cancer　→　15. Section for Studies on Metastasis

R

rat genome study　→　14. Carcinogenesis Division
registry　→　9. Cancer Information and Epidemiology Division
restriction landmark genomic scanning (RLGS) analysis　→　13. Oncogene Division
RET proto-oncogene　→　7. Growth Factor Division

S

s-myc gene　→　6. Biophysics Division
segregation of partly melted molecules (SPM)　→　13. Oncogene Division
serine/threonine protein phosphatase (PP)　→　14. Carcinogenesis Division
serotonin　→　20. Psychooncology Division
simultaneous hybridization of arbitrarily primed PCR products (SHARP)　→　13. Oncogene Division
single-strand conformation polymorphism (SSCP) analysis　→　13. Oncogene Division
small-cell lung cancer (SCLC)　→　7. Growth Factor Division
staurosporine　→　7. Growth Factor Division
Streptococcus anginosus　→　12. Genetics Division

T

telemedicine　→　9. Cancer Information and Epidemiology Division
terminally ill patient　→　20. Psychooncology Division
thioredoxin　→　16. Section for Studies on Host-immune Response
topoisomerase I inhibitor　→　5. Pharmacology Division
toxohormone　→　7. Growth Factor Division
transgenic rat　→　3. Chemotherapy Division
tumor suppressor gene　→　4. Biology Division
tumor-regressing factor　→　3. Chemotherapy Division

V

vascular endothelial growth factor (VEGF)　→　12. Genetics Division, 19. Investigative Treatment Division

Table of Contents